AIKI Insider Trading

Insider Ownership Percentage: 8.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

AIkido Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at AIkido Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AIkido Pharma Share Price & Price History

Current Price: $1.86
Price Change: +0.30 (1.20%)
As of 07/17/2024 01:00 AM ET

This chart shows the closing price history over time for AIKI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

AIkido Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2022Kyle Michael WoolDirectorBuy5,000$3.59$17,950.00266,792View SEC Filing Icon  
12/15/2022Kyle Michael WoolDirectorBuy5,000$3.69$18,450.00280,322View SEC Filing Icon  
12/14/2022Anthony HayesCEOBuy4,500$3.69$16,605.00176,681View SEC Filing Icon  
12/12/2022Anthony HayesCEOBuy5,000$3.62$18,100.00167,181View SEC Filing Icon  
12/9/2022Anthony HayesCEOBuy5,000$3.68$18,400.00162,181View SEC Filing Icon  
12/7/2022Anthony HayesCEOBuy5,000$3.48$17,400.00152,181View SEC Filing Icon  
9/16/2022Kyle Michael WoolDirectorBuy3,559$6.54$23,275.86230,281View SEC Filing Icon  
9/14/2022Soo YuDirectorBuy1,477$6.12$9,039.2483,701View SEC Filing Icon  
9/12/2022Anthony HayesCEOBuy38,208$6.33$241,856.64122,224View SEC Filing Icon  
9/12/2022Soo YuDirectorBuy44,895$6.33$284,185.3552,895View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for AIkido Pharma (NASDAQ:AIKI)

10.88% of AIkido Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AIKI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

AIkido Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/11/2022Equitec Proprietary Markets LLC18,800$0.13M0.0%-70.3%0.358%Search for SEC Filing on Google Icon
7/18/2022Equitec Proprietary Markets LLC63,277$0.37M0.1%-78.7%1.205%Search for SEC Filing on Google Icon
4/22/2022Equitec Proprietary Markets LLC297,765$0.13M0.0%N/A0.333%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP151,591$0.13M0.0%-50.6%0.169%Search for SEC Filing on Google Icon
10/26/2021Game Plan Financial Advisors LLC40,000$33K0.0%N/A0.045%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC853,211$0.82M0.0%N/A0.951%Search for SEC Filing on Google Icon
8/16/2021State Street Corp317,314$0.30M0.0%N/A0.354%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.216,203$0.21M0.0%N/A0.241%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC913,373$0.87M0.0%N/A1.020%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC696,056$0.67M0.0%+13.1%0.777%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.4,136,875$3.96M0.0%-4.5%4.621%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP306,931$0.29M0.0%N/A0.343%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC195,885$0.22M0.0%+121.8%0.219%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC346,382$0.40M0.0%+310.2%0.387%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp44,191$50K0.0%N/A0.049%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp150,654$0.17M0.0%+417.6%0.169%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC615,177$0.70M0.0%+345.0%0.692%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,542,219$1.76M0.0%+2,753,862.5%1.735%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC88,326$77K0.0%N/A0.253%Search for SEC Filing on Google Icon
8/14/2020Sabby Management LLC342,121$0.28M0.1%N/A0.980%Search for SEC Filing on Google Icon
8/7/2020Virtu Financial LLC84,325$69K0.0%N/A0.241%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG101,063$83K0.0%N/A0.289%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
AIkido Pharma logo
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.
Read More on AIkido Pharma

Today's Range

Now: $1.86
Low: $1.85
High: $1.95

50 Day Range

MA: $2.05
Low: $1.86
High: $2.35

52 Week Range

Now: $1.86
Low: $3.31
High: $11.48

Volume

20,889 shs

Average Volume

79,326 shs

Market Capitalization

$10.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

Who are the company insiders with the largest holdings of AIkido Pharma?

AIkido Pharma's top insider investors include:
  1. Kyle Michael Wool (Director)
  2. Anthony Hayes (CEO)
  3. Soo Yu (Director)
Learn More about top insider investors at AIkido Pharma.